CNBS vs MSOS
Amplify Seymour Cannabis ETF against AdvisorShares Pure US Cannabis ETF: cost, size, returns, what they hold and how much of it is the same.
Overlap by weight
10%
1 shared positions
Fee gap
2 bp
CNBS is cheaper
1-year return gap
3.3 pts
MSOS is ahead
Larger fund
MSOS
$839M
Side by side
| CNBS | MSOS | |
|---|---|---|
| Fund | Amplify Seymour Cannabis ETF | AdvisorShares Pure US Cannabis ETF |
| Issuer | Amplify | AdvisorShares |
| Category | Cannabis | Cannabis |
| Expense ratio | 0.76% | 0.78% |
| Assets | $68M | $839M |
| Average daily dollar volume | $170K | $26M |
| Listed | Jul 15, 2019 | Sep 1, 2020 |
| FrenzyCap score | 15 | 37 |
| 1-month return | −11.3% | −10.1% |
| 3-month return | −9.1% | −7.7% |
| Year to date | −12.0% | −8.1% |
| 1-year return | −22.9% | −19.6% |
| 30-day volatility | 45.7% | 52.1% |
| Worst drawdown, 1 year | −51.2% | −52.9% |
| Trailing 12-month yield | — | — |
| Holdings | 39 | 61 |
| Top 10 weight | 144.3% | 32.1% |
| Look-through P/E | — | — |
| Holdings vs fair value | +43.2% | — |
| Holdings above 200-day average | — | — |
| Net flow, latest 3 reported months | −$12M thru Jun 2026 | +$11M thru Jun 2026 |
| 30-day implied volatility | 55.1% | 67.0% |
| Holdings as of | as of Oct 9, 2026issuer data | as of Jun 30, 2026SEC filing |
Returns are price returns and exclude distributions. Flows are each fund's own latest reported months and may not cover the same period.
Largest shared holdings
15% of CNBS · 10% of MSOS| Holding | CNBS | MSOS |
|---|---|---|
| TRLV | 14.88% | 9.56% |
Sector mix of the stock holdings
| Sector | CNBS | MSOS | Gap |
|---|---|---|---|
| Health Care | 15.9% | 10.5% | +5.4% |
| Real Estate | 3.3% | 0.0% | +3.3% |
| Consumer Discretionary | 1.2% | 0.0% | +1.2% |
| Consumer Staples | 0.3% | 0.3% | +0.0% |
More: full overlap table · CNBS holdings · MSOS holdings
Fund data comes from each fund's SEC filings and issuer disclosures and is shown with the date it is as of. SEC portfolio and flow filings become public about 60 days after the period they cover. Nothing here is investment advice; see Terms.